Transient Exacerbation of Nasal Symptoms following Endoscopic Transsphenoidal Surgery for Pituitary Tumors: A Prospective Study

Abstract

Object Endoscopic transsphenoidal surgery is the commonest approach to pituitary tumors. One disadvantage of this approach is the development of early postoperative nasal symptoms. Our aim was to clarify the peak onset of these symptoms and their temporal evolution.

Methods The General Nasal Patient Inventory (GNPI) was administered to 56 patients undergoing endoscopic transsphenoidal surgery for pituitary tumors preoperatively and at 1 day, 3 days, 2 weeks, 3 months, and 6 to 12 months postoperatively. Most patients underwent surgery for pituitary adenomas (N = 49; 88%) and through a uninostril approach (N = 55; 98%). Total GNPI (0–135) and scores for the 45 individual components were compared.

Results GNPI scores peaked at 1 to 3 days postoperatively, with rapid reduction to baseline by 2 weeks and below baseline by 6 to 12 months postsurgery (p < 0.01). Of the 45 individual symptoms on the GNPI scale, 19 (42%) worsened transiently after surgery (p < 0.05). Functioning tumors had a higher GNPI scores at postoperative day 1 and 3 than nonfunctioning tumors, although their temporal evolution was the same (p < 0.05).

Conclusions Nasal morbidity following endoscopic transsphenoidal pituitary surgery is common, but transient, more so in the functioning subgroup. Nasal symptoms improve below baseline by 6 to 12 months, without the need for specific long-term postoperative interventions in the vast majority of patients.

Keywords

endoscopic - transsphenoidal - pituitary tumor - adenoma - nasal symptoms - GNPI

• References

• 1 Zador Z, Gnanalingham K. Endoscopic transnasal approach to the pituitary--operative technique and nuances. Br J Neurosurg 2013; 27 (06) 718-726
• 2 Little AS, Kelly D, Milligan J. , et al. Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery. J Neurosurg 2015; 122 (06) 1458-1465
• 3 McCoul ED, Anand VK, Schwartz TH. Improvements in site-specific quality of life 6 months after endoscopic anterior skull base surgery: a prospective study. J Neurosurg 2012; 117 (03) 498-506
• 4 Wang YY, Srirathan V, Tirr E, Kearney T, Gnanalingham KK. Nasal symptoms following endoscopic transsphenoidal pituitary surgery: assessment using the General Nasal Patient Inventory. Neurosurg Focus 2011; 30 (04) E12
• 5 Gao Y, Zhong C, Wang Y. , et al. Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis. World J Surg Oncol 2014; 12: 94
• 6 Little AS, Kelly DF, Milligan J. , et al. Comparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study. J Neurosurg 2015; 123 (03) 799-807
• 7 Kirkman MA, Borg A, Al-Mousa A, Haliasos N, Choi D. Quality-of-life after anterior skull base surgery: a systematic review. J Neurol Surg B Skull Base 2014; 75 (02) 73-89
• 8 Little AS, Kelly D, Milligan J. , et al. Prospective validation of a patient-reported nasal quality-of-life tool for endonasal skull base surgery: The Anterior Skull Base Nasal Inventory-12. J Neurosurg 2013; 119 (04) 1068-1074
• 9 Fathalla H, Cusimano MD, Alsharif OM, Jing R. Endoscopic transphenoidal surgery for acromegaly improves quality of life. Can J Neurol Sci 2014; 41 (06) 735-741
• 10 Gaillard S. The transition from microscopic to endoscopic transsphenoidal surgery in high-caseload neurosurgical centers: the experience of Foch Hospital. World Neurosurg 2014; 82 (6, Suppl): S116-S120
• 11 Jane Jr JA, Han J, Prevedello DM, Jagannathan J, Dumont AS, Laws Jr ER. Perspectives on endoscopic transsphenoidal surgery. Neurosurg Focus 2005; 19 (06) E2
• 12 Humphreys H. Preventing surgical site infection. Where now?. J Hosp Infect 2009; 73 (04) 316-322
• 13 Little AS, Chapple K, Jahnke H, White WL. Comparative inpatient resource utilization for patients undergoing endoscopic or microscopic transsphenoidal surgery for pituitary lesions. J Neurosurg 2014; 121 (01) 84-90
• 14 Douglas SA, Marshall AH, Walshaw D, Robson AK, Wilson JA. The development of a General Nasal Patient Inventory. Clin Otolaryngol Allied Sci 2001; 26 (05) 425-429
• 15 Balaker AE, Bergsneider M, Martin NA, Wang MB. Evolution of sinonasal symptoms following endoscopic anterior skull base surgery. Skull Base 2010; 20 (04) 245-251
• 16 Dusick JR, Esposito F, Mattozo CA, Chaloner C, McArthur DL, Kelly DF. Endonasal transsphenoidal surgery: the patient's perspective-survey results from 259 patients. Surg Neurol 2006; 65 (04) 332-341 , discussion 341–342
• 17 Actor B, Sarnthein J, Prömmel P, Holzmann D, Bernays RL. Olfactory improvement in acromegaly after transnasal transsphenoidal surgery. Neurosurg Focus 2010; 29 (04) E10
• 18 Leach P, Abou-Zeid AH, Kearney T, Davis J, Trainer PJ, Gnanalingham KK. Endoscopic transsphenoidal pituitary surgery: evidence of an operative learning curve. Neurosurgery 2010; 67 (05) 1205-1212
• 19 Wicke C, Halliday B, Allen D. , et al. Effects of steroids and retinoids on wound healing. Arch Surg 2000; 135 (11) 1265-1270
• 20 Rudmik L, Soler ZM, Orlandi RR. , et al. Early postoperative care following endoscopic sinus surgery: an evidence-based review with recommendations. Int Forum Allergy Rhinol 2011; 1 (06) 417-430
• 21 de Almeida JR, Snyderman CH, Gardner PA, Carrau RL, Vescan AD. Nasal morbidity following endoscopic skull base surgery: a prospective cohort study. Head Neck 2010; 33 (04) 547-551